Sarah Elitzur

2.2k total citations
33 papers, 306 citations indexed

About

Sarah Elitzur is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Sarah Elitzur has authored 33 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Public Health, Environmental and Occupational Health, 10 papers in Pediatrics, Perinatology and Child Health and 10 papers in Oncology. Recurrent topics in Sarah Elitzur's work include Acute Lymphoblastic Leukemia research (19 papers), Childhood Cancer Survivors' Quality of Life (9 papers) and Acute Myeloid Leukemia Research (4 papers). Sarah Elitzur is often cited by papers focused on Acute Lymphoblastic Leukemia research (19 papers), Childhood Cancer Survivors' Quality of Life (9 papers) and Acute Myeloid Leukemia Research (4 papers). Sarah Elitzur collaborates with scholars based in Israel, Germany and Netherlands. Sarah Elitzur's co-authors include Gil Gilad, Shai Izraeli, Andishe Attarbaschi, Galia Avrahami, Nira Arad‐Cohen, Jan Starý, Ronit Nirel, Ronit Elhasid, Martin Schrappe and Franco Locatelli and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Sarah Elitzur

28 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Elitzur Israel 12 172 118 91 70 61 33 306
Bénedicte Bruno France 10 53 0.3× 132 1.1× 73 0.8× 91 1.3× 41 0.7× 24 280
Rehan M. Faridi India 11 95 0.6× 58 0.5× 30 0.3× 36 0.5× 50 0.8× 27 460
J. A. Holmes United Kingdom 8 130 0.8× 98 0.8× 35 0.4× 161 2.3× 126 2.1× 13 357
Holly Miller United States 9 49 0.3× 229 1.9× 78 0.9× 88 1.3× 35 0.6× 29 401
Galia Avrahami Israel 9 111 0.6× 28 0.2× 43 0.5× 23 0.3× 40 0.7× 15 257
Agnieszka Zaucha‐Prażmo Poland 10 65 0.4× 94 0.8× 57 0.6× 68 1.0× 23 0.4× 50 253
Evgeniya Polushkina Russia 8 73 0.4× 56 0.5× 54 0.6× 93 1.3× 24 0.4× 18 209
Vilma Carolina Bekker‐Méndez Mexico 8 65 0.4× 36 0.3× 39 0.4× 28 0.4× 73 1.2× 45 243
Lara Carvalho Godói Brazil 14 81 0.5× 76 0.6× 214 2.4× 9 0.1× 34 0.6× 26 474
William W. Terry United States 10 31 0.2× 33 0.3× 29 0.3× 90 1.3× 127 2.1× 21 308

Countries citing papers authored by Sarah Elitzur

Since Specialization
Citations

This map shows the geographic impact of Sarah Elitzur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Elitzur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Elitzur more than expected).

Fields of papers citing papers by Sarah Elitzur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Elitzur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Elitzur. The network helps show where Sarah Elitzur may publish in the future.

Co-authorship network of co-authors of Sarah Elitzur

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Elitzur. A scholar is included among the top collaborators of Sarah Elitzur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Elitzur. Sarah Elitzur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sluis, Inge M. van der, Erica Brivio, Raheel Altaf Raja, et al.. (2025). Therapeutic drug monitoring in acute lymphoblastic leukemia–a deep dive into pharmacokinetics, -dynamics, and -genetics of antileukemic drugs. Expert Review of Clinical Pharmacology. 18(3). 131–149. 1 indexed citations
3.
Stoltze, Ulrik Kristoffer, Stefanie V. Junk, Hélène Cavé, et al.. (2025). Overt and covert genetic causes of pediatric acute lymphoblastic leukemia. Leukemia. 39(5). 1031–1045.
4.
Marcu‐Malina, Victoria, Ifat Sarouk, Amilia Meir, et al.. (2024). Genotoxicity Associated with Retroviral CAR Transduction of ATM -Deficient T Cells. Blood Cancer Discovery. 5(4). 267–275. 1 indexed citations
5.
Möricke, Anja, Draga Barbaric, Neil D. Jones, et al.. (2024). Pneumocystis jirovecii pneumonia in paediatric acute lymphoblastic leukaemia: A report from the multi‐international clinical trial AIEOP‐BFM ALL 2009. British Journal of Haematology. 204(6). 2319–2323. 2 indexed citations
6.
Wagener, Rabea, Sarah Elitzur, Triantafyllia Brozou, & Arndt Borkhardt. (2023). Functional damaging germline variants in ETV6, IKZF1, PAX5 and RUNX1 predisposing to B-cell precursor acute lymphoblastic leukemia. European Journal of Medical Genetics. 66(4). 104725–104725. 5 indexed citations
7.
Rizzari, Carmelo, Anja Möricke, Maria Grazia Valsecchi, et al.. (2023). Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol. HemaSphere. 7(6). e893–e893. 5 indexed citations
8.
Pastorczak, Agata, Andishe Attarbaschi, Simon Bomken, et al.. (2022). Consensus Recommendations for the Clinical Management of Hematological Malignancies in Patients with DNA Double Stranded Break Disorders. Cancers. 14(8). 2000–2000. 11 indexed citations
9.
Lehrnbecher, Thomas, Andreas H. Groll, Simone Cesaro, et al.. (2022). Invasive fungal diseases impact on outcome of childhood ALL – an analysis of the international trial AIEOP-BFM ALL 2009. Leukemia. 37(1). 72–78. 19 indexed citations
10.
Benish, Marganit, Sarah Elitzur, Nira Arad‐Cohen, et al.. (2022). Invasive Fusariosis in Pediatric Hematology/Oncology and Stem Cell Transplant Patients: A Report from the Israeli Society of Pediatric Hematology-Oncology. Journal of Fungi. 8(4). 387–387. 8 indexed citations
11.
Elitzur, Sarah, Assaf Arie Barg, Gil Gilad, et al.. (2021). Delayed diagnosis and treatment of children with cancer during the COVID-19 pandemic. International Journal of Clinical Oncology. 26(8). 1569–1574. 18 indexed citations
12.
Elitzur, Sarah, Helen Toledano, Gil Gilad, et al.. (2021). COVID-19 infection in pediatric patients treated for cancer. International Journal of Clinical Oncology. 27(2). 448–454. 2 indexed citations
13.
Elitzur, Sarah, Tal Goshen‐Lago, Gil Gilad, et al.. (2021). Long-term ovarian reserve and fertility outcomes in female survivors of childhood acute lymphoblastic leukemia. Leukemia & lymphoma. 62(9). 2211–2218. 4 indexed citations
14.
Elitzur, Sarah, Nira Arad‐Cohen, Bella Bielorai, et al.. (2019). Blinatumomab as a bridge to further therapy in cases of overwhelming toxicity in pediatric B‐cell precursor acute lymphoblastic leukemia: Report from the Israeli Study Group of Childhood Leukemia. Pediatric Blood & Cancer. 66(10). e27898–e27898. 21 indexed citations
15.
Arad‐Cohen, Nira, Ronit Nirel, Galia Avrahami, et al.. (2019). Thrombophilia screening and thromboprophylaxis may benefit specific ethnic subgroups with paediatric acute lymphoblastic leukaemia. British Journal of Haematology. 184(6). 994–998. 11 indexed citations
16.
Elitzur, Sarah, Shlomit Barzilai, Assaf Arie Barg, et al.. (2018). Mucormycosis Among Children with Hematological Malignancies Is Associated with High-Risk Acute Lymphoblastic Leukemia and Is Often Salvageable. Blood. 132(Supplement 1). 3964–3964.
17.
Elitzur, Sarah, Galia Avrahami, Shlomit Barzilai, et al.. (2017). Growth and pubertal patterns in young survivors of childhood acute lymphoblastic leukemia. Journal of Pediatric Endocrinology and Metabolism. 30(8). 869–877. 11 indexed citations
18.
Gilad, Oded, Orly Dgany, Sarah Elitzur, et al.. (2014). Characterization of Two Unique α-Globin Gene Cluster Deletions Causing α-Thalassemia in Israeli Arabs. Hemoglobin. 38(5). 319–324. 9 indexed citations
19.
Bachas, Costa, Gerrit Jan Schuurhuis, Dirk Reinhardt, et al.. (2014). Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapse. British Journal of Haematology. 166(6). 902–910. 15 indexed citations
20.
Elitzur, Sarah, Joanne Yacobovich, Orly Dgany, et al.. (2013). From Blood Smear to Lipid Disorder. Journal of Pediatric Hematology/Oncology. 35(8). e329–e331. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bénedicte Bruno Breakdown of academic impact, for papers by Rehan M. Faridi Breakdown of academic impact, for papers by J. A. Holmes Breakdown of academic impact, for papers by Holly Miller Breakdown of academic impact, for papers by Galia Avrahami Breakdown of academic impact, for papers by Agnieszka Zaucha‐Prażmo Breakdown of academic impact, for papers by Evgeniya Polushkina Breakdown of academic impact, for papers by Vilma Carolina Bekker‐Méndez Breakdown of academic impact, for papers by Lara Carvalho Godói Breakdown of academic impact, for papers by William W. Terry
Rankless by CCL
2026